Clinical trial
Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia
NCT03363113 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- July 12, 2016
- Enrollment
- 240 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dystonia; orofacial